Transgender man receiving testosterone treatment became pregnant and delivered a girl: A case report.
case report
contraception
pregnancy
testosterone
transgender persons
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
revised:
20
12
2021
received:
06
10
2021
accepted:
27
12
2021
pubmed:
8
1
2022
medline:
5
3
2022
entrez:
7
1
2022
Statut:
ppublish
Résumé
Many transgender men receive testosterone therapy to achieve virilization. The therapy is often mistaken for having a contraceptive effect because it causes amenorrhea. However, some treated patients become pregnant, which is not well known. A 25-year-old transgender man who had received testosterone for 3 years had an unplanned pregnancy during discontinuation of treatment. He was unaware of his pregnancy, resumed testosterone, and continued treatment until pregnancy was confirmed. His female child was exposed to androgens during the fetal period; thus, careful, long-term observation was required. He developed insomnia and depression during the postpartum, and giving birth made it difficult for him to change his family register to male. Transgender men can become pregnant through sexual intercourse with biological men, even during hormone replacement therapy, so correct contraception is necessary to avoid unwanted pregnancies. Transgender sex education is important to increase awareness of this issue among individuals and medical professionals.
Substances chimiques
Androgens
0
Testosterone
3XMK78S47O
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
866-868Informations de copyright
© 2022 Japan Society of Obstetrics and Gynecology.
Références
Conron KJ, Scott G, Stowell GS, Landers SJ. Transgender health in Massachusetts: results from a household probability sample of adults. Am J Public Health. 2012;102:118-22.
Committee on Health Care for Underserved Women. Committee opinion no. 512: health care for transgender individuals. Obstet Gynecol. 2011;118:1454-8.
Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124:1120-7.
World Professional Association for Transgender Health: Standards of care for the health of transsexual, transgender, and gender nonconforming people (7th Version). 2011. [Cited 20 Apr 2021.] Available from: https://www.wpath.org/publications/soc
Goy RW. Differentiation of male social traits in female rhesus macaques by prenatal treatment with androgens: variation in type of androgen, duration, and timing of treatment. In: Novy MJ, Resko JA, editors. Fetal Endocrinology. New York: Academic Press; 1981. p. 319-39.
Baba T, Endo T, Honnma H, Kitajima Y, Hayashi T, Ikeda H, et al. Association between polycystic ovary syndrome and female-to-male transsexuality. Hum Reprod. 2007;22:1011-6.
Ostatníková D, Lakatošová S, Babková J, Hodosy J, Celec P. Testosterone and the brain: from cognition to autism. Physiol Res. 2020;69:S403-19.
Obedin-Maliver J, Makadon HJ. Transgender men and pregnancy. Obstet Med. 2016;9:4-8.